B-CELL PRECURSOR BONE-MARROW RECONSTITUTION AFTER BONE-MARROW TRANSPLANTATION

被引:32
|
作者
LEITENBERG, D [1 ]
RAPPEPORT, JM [1 ]
SMITH, BR [1 ]
机构
[1] YALE UNIV,SCH MED,DEPT INTERNAL MED,NEW HAVEN,CT 06510
关键词
BONE MARROW TRANSPLANTATION; IMMUNOGLOBULIN GENE REARRANGEMENT; IMMUNOPHENOTYPE; PRE-B CELLS;
D O I
10.1093/ajcp/102.2.231
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Bone marrow transplantation is characterized by a prolonged period of humoral immunodeficiency in which many patients have abnormal circulating B-cell subsets, and oligoclonal and monoclonal gammopathies. In this study we examine B-cell precursor reconstitution in the posttransplantation marrow. Within 1 month after transplantation there is a marked increase in the percentage of immature B cells (to 80% of marrow lymphocytes), which can persist for more than 1 year. The increase in B-cell precursors is seen in both adults and children and appears to be independent of age. These cells have a normal precursor B-cell surface antigenic phenotype (CD19+, CD10+, CD20 negative to dim) and generally express very little CD34. No monoclonal or oligoclonal immunoglobulin gene rearrangements are detected in these cells, which enables them to be easily distinguishable from common precursor B-cell acute lymphocytic leukemia lymphoblasts.
引用
收藏
页码:231 / 236
页数:6
相关论文
共 50 条
  • [41] PSYCHOLOGICAL ISSUES FOLLOWING BONE-MARROW TRANSPLANTATION
    SOUSSAIN, C
    AMIELLEBIGRE, F
    BULLETIN DU CANCER, 1992, 79 (12) : 1135 - 1148
  • [42] BONE-MARROW TRANSPLANTATION FOR INFANTILE MALIGNANT OSTEOPETROSIS
    SOLH, H
    DACUNHA, AM
    GIRI, N
    PADMOS, A
    SPENCE, D
    CLINK, H
    ERNST, P
    SAKATI, N
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1995, 17 (04) : 350 - 355
  • [43] BONE-MARROW TRANSPLANTATION FOR ACUTE NONLYMPHOBLASTIC LEUKEMIA
    LJUNGMAN, P
    GAHRTON, G
    LEUKEMIA & LYMPHOMA, 1992, 7 (1-2) : 7 - 14
  • [44] BONE-MARROW TRANSPLANTATION FOR THALASSEMIA - THE USA EXPERIENCE
    WALTERS, MC
    THOMAS, ED
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1994, 16 (01): : 11 - 17
  • [45] TREATMENT OF BONE-MARROW FAILURE SECONDARY TO NUCLEAR ACCIDENTS - BONE-MARROW TRANSPLANTATION OR HEMATOPOIETIC GROWTH-FACTORS
    DEREVEL, T
    NEDELLEC, G
    AUZANNEAU, G
    MEDECINE ET ARMEES, 1991, 19 (02): : 75 - 79
  • [46] BONE-MARROW TRANSPLANTATION - REVIEW AND ESSEN RESULTS
    SCHAEFER, UW
    ZENTRALBLATT FUR CHIRURGIE, 1992, 117 (12): : 701 - 703
  • [47] INFREQUENT SITES OF EXTRAMEDULLARY RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    VIARD, F
    BILHOUNABERA, C
    MARIT, G
    DURRIEU, F
    DUBUS, P
    MASSERON, T
    BOIRON, JM
    GHARBI, MJ
    SALZES, S
    BROUSTET, A
    REIFFERS, J
    BERNARD, P
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1995, 37 (02): : 153 - 157
  • [48] ANALYSIS OF EARLY RECONSTITUTION EVENTS IN THE SCID MOUSE THYMUS FOLLOWING RAT BONE-MARROW CELL TRANSPLANTATION
    PRAKAPAS, Z
    DENOYELLE, M
    THIERY, JP
    DEUGNIER, MA
    IMMUNOLOGY LETTERS, 1993, 37 (01) : 63 - 71
  • [49] ANTIBACTERIAL POLYSACCHARIDE ANTIBODY DEFICIENCY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    QUINTI, I
    VELARDI, A
    LEMOLI, S
    GUERRA, E
    DAMELIO, R
    MASTRANTONIO, P
    MARTELLI, MF
    AIUTI, F
    JOURNAL OF CLINICAL IMMUNOLOGY, 1990, 10 (03) : 160 - 166
  • [50] DIFFUSE PULMONARY ALVEOLAR HEMORRHAGE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    SCHMIDTWOLF, I
    SCHWERDTFEGER, R
    SCHWELLA, N
    GALLARDO, J
    SCHMID, HJ
    HUHN, D
    SIEGERT, W
    ANNALS OF HEMATOLOGY, 1993, 67 (03) : 139 - 141